There is no statement that 80% of people with hepatitis B minor triple positive do not develop disease in their lifetime. Whether or not a person with hepatitis B is morbid is related to factors such as the immune status of the infected person. Hepatitis B triple 3 patients have both morbid and non-morbid outcomes. When the autoimmune system of hepatitis B triple 3 patients is low-functioning or immune imbalance, it may lead to active and massive replication of hepatitis B virus in the body, resulting in abnormal liver function of hepatitis B triple 3 patients, which is the morbid stage and requires timely antiviral treatment. The other outcome of hepatitis B minor triple positive people is that they do not have morbidity. Hepatitis B virus carriers have stable conditions, hepatitis B virus replication is not active, viral load is small, and liver function remains normal. If the body’s immune system functions normally and there is a balance between the immune system and the hepatitis B virus, there is a possibility of lifelong non-incidence. Nowadays there is no such thing as 80% of people with hepatitis B minor triple positive not developing disease. People with Hepatitis B minor tri-positive should have medical checkups on time and follow the doctor’s instructions for standardized treatment to avoid progression of the disease.